FDA Approved Products

Application #TypeSponsorNotesProduct #Drug NameFormStrengthActive IngredientApproval DateMarketing StatusReference Standard
212905NDAVERRICA PHARMS001YCANTHSOLUTION;TOPICAL0.7%CANTHARIDIN2023-07-21PrescriptionYes